GH
Glucose Health, Inc.
SEC filingManufacturing · Bentonville, AR
Amount raised$10Ksold at filing
Total offering$30K$20K still open
Investors in the raise1count reported to the SEC
FiledSep 10, 2026first sale Aug 28, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Mark SchaftleinDirector
Christopher JemapeteDirector
John DuffyExecutive Officer, Director
Edmund BurkeDirector
marc HatchExecutive Officer
Executive officers, directors and promoters as listed on the Form D.